260 related articles for article (PubMed ID: 18483177)
1. Progesterone receptor inhibits aromatase and inflammatory response pathways in breast cancer cells via ligand-dependent and ligand-independent mechanisms.
Hardy DB; Janowski BA; Chen CC; Mendelson CR
Mol Endocrinol; 2008 Aug; 22(8):1812-24. PubMed ID: 18483177
[TBL] [Abstract][Full Text] [Related]
2. Role of the progesterone receptor (PR) in the regulation of inflammatory response pathways and aromatase in the breast.
Mendelson CR; Hardy DB
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):241-9. PubMed ID: 17049843
[TBL] [Abstract][Full Text] [Related]
3. Progesterone receptor plays a major antiinflammatory role in human myometrial cells by antagonism of nuclear factor-kappaB activation of cyclooxygenase 2 expression.
Hardy DB; Janowski BA; Corey DR; Mendelson CR
Mol Endocrinol; 2006 Nov; 20(11):2724-33. PubMed ID: 16772530
[TBL] [Abstract][Full Text] [Related]
4. HER-2/neu status is a determinant of mammary aromatase activity in vivo: evidence for a cyclooxygenase-2-dependent mechanism.
Subbaramaiah K; Howe LR; Port ER; Brogi E; Fishman J; Liu CH; Hla T; Hudis C; Dannenberg AJ
Cancer Res; 2006 May; 66(10):5504-11. PubMed ID: 16707480
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory status influences aromatase and steroid receptor expression in endometriosis.
Bukulmez O; Hardy DB; Carr BR; Word RA; Mendelson CR
Endocrinology; 2008 Mar; 149(3):1190-204. PubMed ID: 18048499
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of steroid receptors (estrogen receptor alpha and/or progesterone receptors) and Her-2/neu: Clinical implications.
Ciocca DR; Gago FE; Fanelli MA; Calderwood SK
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):32-40. PubMed ID: 17049840
[TBL] [Abstract][Full Text] [Related]
7. Aromatase and COX in breast cancer: enzyme inhibitors and beyond.
Brueggemeier RW; Su B; Sugimoto Y; Díaz-Cruz ES; Davis DD
J Steroid Biochem Mol Biol; 2007; 106(1-5):16-23. PubMed ID: 17616393
[TBL] [Abstract][Full Text] [Related]
8. Cyclic AMP enhances progesterone action in human myometrial cells.
Chen L; Lei K; Malawana J; Yulia A; Sooranna SR; Bennett PR; Liang Z; Grammatopoulos D; Johnson MR
Mol Cell Endocrinol; 2014 Jan; 382(1):334-343. PubMed ID: 24161591
[TBL] [Abstract][Full Text] [Related]
9. Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies.
Milosevic J; Klinge J; Borg AL; Foukakis T; Bergh J; Tobin NP
BMC Cancer; 2013 Oct; 13():473. PubMed ID: 24119434
[TBL] [Abstract][Full Text] [Related]
10. Progesterone receptor inhibits proliferation of human breast cancer cells via induction of MAPK phosphatase 1 (MKP-1/DUSP1).
Chen CC; Hardy DB; Mendelson CR
J Biol Chem; 2011 Dec; 286(50):43091-102. PubMed ID: 22020934
[TBL] [Abstract][Full Text] [Related]
11. Translational studies on aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer.
Brueggemeier RW; Díaz-Cruz ES; Li PK; Sugimoto Y; Lin YC; Shapiro CL
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):129-36. PubMed ID: 15964185
[TBL] [Abstract][Full Text] [Related]
12. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.
Konecny G; Pauletti G; Pegram M; Untch M; Dandekar S; Aguilar Z; Wilson C; Rong HM; Bauerfeind I; Felber M; Wang HJ; Beryt M; Seshadri R; Hepp H; Slamon DJ
J Natl Cancer Inst; 2003 Jan; 95(2):142-53. PubMed ID: 12529347
[TBL] [Abstract][Full Text] [Related]
13. The role of cyclooxygenase-2-dependent signaling via cyclic AMP response element activation on aromatase up-regulation by o,p'-DDT in human breast cancer cells.
Han EH; Kim HG; Hwang YP; Choi JH; Im JH; Park B; Yang JH; Jeong TC; Jeong HG
Toxicol Lett; 2010 Oct; 198(3):331-41. PubMed ID: 20678559
[TBL] [Abstract][Full Text] [Related]
14. Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs.
Knutson TP; Truong TH; Ma S; Brady NJ; Sullivan ME; Raj G; Schwertfeger KL; Lange CA
J Hematol Oncol; 2017 Apr; 10(1):89. PubMed ID: 28412963
[TBL] [Abstract][Full Text] [Related]
15. Relationships between progesterone receptor isoforms and the HER/ErbB receptors and ligands network in 299 primary breast cancers.
Lindet C; Révillion F; Lhotellier V; Hornez L; Peyrat JP; Bonneterre J
Int J Biol Markers; 2012 Jul; 27(2):e111-7. PubMed ID: 22505232
[TBL] [Abstract][Full Text] [Related]
16. Expression of cyclooxygenase-2 and 12-lipoxygenase in human breast cancer and their relationship with HER-2/neu and hormonal receptors: impact on prognosis and therapy.
Mohammad AM; Abdel HA; Abdel W; Ahmed AM; Wael T; Eiman G
Indian J Cancer; 2006; 43(4):163-8. PubMed ID: 17192687
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of intratumoral aromatase messenger RNA levels by docetaxel in human breast cancers.
Miyoshi Y; Kim SJ; Akazawa K; Kamigaki S; Ueda S; Yanagisawa T; Inoue T; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2004 Dec; 10(24):8163-9. PubMed ID: 15623590
[TBL] [Abstract][Full Text] [Related]
18. Progesterone acts via the nuclear glucocorticoid receptor to suppress IL-1β-induced COX-2 expression in human term myometrial cells.
Lei K; Chen L; Georgiou EX; Sooranna SR; Khanjani S; Brosens JJ; Bennett PR; Johnson MR
PLoS One; 2012; 7(11):e50167. PubMed ID: 23209664
[TBL] [Abstract][Full Text] [Related]
19. Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells.
Labriola L; Salatino M; Proietti CJ; Pecci A; Coso OA; Kornblihtt AR; Charreau EH; Elizalde PV
Mol Cell Biol; 2003 Feb; 23(3):1095-111. PubMed ID: 12529413
[TBL] [Abstract][Full Text] [Related]
20. HER-2/neu x aromatase double transgenic mice model: the effects of aromatase overexpression on mammary tumorigenesis.
Tekmal RR; Nair HB; Perla RP; Kirma N
J Steroid Biochem Mol Biol; 2007; 106(1-5):111-8. PubMed ID: 17604617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
